Xtant Medical Holdings, Inc.
XTNT
$0.60
$0.011.83%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 109.96% | -37.41% | -621.48% | -2,592.27% | -738.60% |
| Total Depreciation and Amortization | 11.21% | 14.37% | 15.78% | 33.08% | 65.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.54% | 164.80% | 165.22% | 158.45% | 156.07% |
| Change in Net Operating Assets | 23.93% | 47.23% | 43.88% | -47.19% | 12.60% |
| Cash from Operations | 158.11% | 109.63% | 62.66% | -25.02% | -23.77% |
| Capital Expenditure | 30.10% | -125.33% | -155.56% | -182.49% | -147.66% |
| Sale of Property, Plant, and Equipment | -18.80% | -1.98% | 38.91% | 118.86% | 320.88% |
| Cash Acquisitions | -- | -- | -- | -- | 90.42% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 148.43% | 50.31% | 47.75% | 84.95% | 76.08% |
| Total Debt Issued | -9.09% | -1.54% | 21.90% | 41.36% | 46.92% |
| Total Debt Repaid | -9.49% | -10.00% | -24.50% | -35.72% | -44.05% |
| Issuance of Common Stock | -100.00% | -68.10% | -68.10% | -68.10% | -73.68% |
| Repurchase of Common Stock | 26.98% | 20.14% | 38.85% | 31.80% | -111.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 21.08% | 2.66% | -41.26% | -443.51% | -- |
| Cash from Financing | -139.89% | -83.04% | -50.86% | -18.37% | -30.94% |
| Foreign Exchange rate Adjustments | -224.32% | -194.59% | -308.00% | -720.83% | 169.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 313.77% | 51.36% | 203.18% | 102.04% | 81.22% |